Research Articles | Page 30 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Clonal evolution in aplastic anemia: failed tumor surveillance or maladaptive recovery? Jun 2023 Leukemia & Lymphoma Aplastic Anemia
Fit older adults with advanced myelodysplastic syndromes: who is most likely to benefit from transplant? Nov 2020 Leukemia & Lymphoma Myelodysplastic Syndromes (MDS)
Clinical outcomes and characteristics of patients with TP53-mutated acute myeloid leukemia or myelodysplastic syndromes: a single center experience Sep 2020 Leukemia & Lymphoma Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS)
Rigosertib in Combination With Azacitidine in Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia: Results of a Phase 1 Study Jul 2020 Leukemia Research Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS)
Outcome of lower-risk myelodysplastic syndrome with ring sideroblasts (MDS-RS) after failure of erythropoiesis- stimulating agents Dec 2020 Leukemia Research Myelodysplastic Syndromes (MDS)
A phase 2 trial of the oral smoothened inhibitor glasdegib in refractory myelodysplastic syndromes (MDS) Mar 2019 Leukemia Research Myelodysplastic Syndromes (MDS)
Patient and physician perceptions about blood transfusions in the myelodysplastic syndromes Jul 2020 Leukemia Research Myelodysplastic Syndromes (MDS)
Rewriting the rules for care of MDS and AML patients in the time of COVID-19 Apr 2020 Leukemia Research Reports Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS)
Haploidentical Transplant with Post-Transplant Cyclophosphamide for Acute Myeloid Leukaemia and Myelodysplastic Syndromes Patients: The Role of Previous Lines of Therapy Jan 2024 Mediterranean Journal of Hematology and Infectious Diseases Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS)
TERC haploid cell reprogramming: a novel therapeutic strategy for aplastic anemia Jun 2023 Molecular Medicine Aplastic Anemia